Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.

Science
Mamta TahilianiAnjana Rao

Abstract

DNA cytosine methylation is crucial for retrotransposon silencing and mammalian development. In a computational search for enzymes that could modify 5-methylcytosine (5mC), we identified TET proteins as mammalian homologs of the trypanosome proteins JBP1 and JBP2, which have been proposed to oxidize the 5-methyl group of thymine. We show here that TET1, a fusion partner of the MLL gene in acute myeloid leukemia, is a 2-oxoglutarate (2OG)- and Fe(II)-dependent enzyme that catalyzes conversion of 5mC to 5-hydroxymethylcytosine (hmC) in cultured cells and in vitro. hmC is present in the genome of mouse embryonic stem cells, and hmC levels decrease upon RNA interference-mediated depletion of TET1. Thus, TET proteins have potential roles in epigenetic regulation through modification of 5mC to hmC.

References

Mar 30, 1988·Biochemical and Biophysical Research Communications·S V CannonG W Teebor
Dec 19, 1967·Biochimica Et Biophysica Acta·A H Alegria
Jun 19, 1981·Science·M Ehrlich, R Y Wang
Jun 1, 1996·Chemical Research in Toxicology·E Privat, L C Sowers
Apr 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·B ZhuJ P Jost
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·V Rusmintratip, L C Sowers
Jan 10, 2002·Genes & Development·Adrian Bird
Nov 7, 1996·Chemical Reviews·Lawrence Que, Raymond Y. N. Ho
Jun 15, 2005·Annual Review of Biochemistry·Mary Grace Goll, Timothy H Bestor
Oct 17, 2007·Annual Review of Medicine·Einav Nili Gal-YamPeter A Jones
Feb 19, 2008·Nature Chemical Biology·Christoph Loenarz, Christopher J Schofield
Mar 7, 2008·Nature·Raphaël MétivierGilles Salbert
Mar 7, 2008·Nature·Sara KangaspeskaGeorge Reid
Jul 1, 2008·Cell·Steen K T Ooi, Timothy H Bestor
Aug 30, 2008·Annual Review of Microbiology·Piet Borst, Robert Sabatini
Dec 27, 2008·Cell·Josef Jiricny, Mirco Menigatti

❮ Previous
Next ❯

Citations

Mar 3, 2010·Annals of Hematology·Ulrike BacherTorsten Haferlach
Sep 18, 2009·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Jamie R WeaverMarisa S Bartolomei
Sep 10, 2013·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Sivan Vadakkadath MeethalBermans J Iskandar
Nov 4, 2011·Chromosoma·Angelika L Jacobs, Primo Schär
Mar 20, 2012·Chromosoma·Martin Leeb, Anton Wutz
Nov 9, 2012·Molecules and Cells·Yoshiaki TanakaIn-Hyun Park
Sep 6, 2011·Functional & Integrative Genomics·Ehsan HabibiStephen J Haggarty
Nov 1, 2012·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Musashi KubiuraMasako Tada
Nov 15, 2012·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Garry T MorganMichel Bellini
May 18, 2013·Chromosome Research : an International Journal on the Molecular, Supramolecular and Evolutionary Aspects of Chromosome Biology·Brendan Evano, Shahragim Tajbakhsh
Mar 23, 2011·Ecotoxicology·Michiel B Vandegehuchte, Colin R Janssen
Feb 21, 2013·Current Atherosclerosis Reports·Hannes M FindeisenDennis Bruemmer
Feb 23, 2011·Current Hematologic Malignancy Reports·Ramon V TiuJaroslaw P Maciejewski
Dec 16, 2011·Current Hematologic Malignancy Reports·Madappa N KundrandaRuben A Mesa
Dec 28, 2011·Current Hematologic Malignancy Reports·Elodie Pronier, François Delhommeau
Nov 6, 2013·Current Hematologic Malignancy Reports·Nicole C C Them, Robert Kralovics
Sep 1, 2011·Journal of Ocular Biology, Diseases, and Informatics·Deborah C Otteson
Feb 27, 2010·International Journal of Hematology·François DelhommeauNicole Casadevall
Sep 28, 2012·International Journal of Hematology·Young Rock ChungOmar Abdel-Wahab
Oct 12, 2012·International Journal of Hematology·Goro Sashida, Atsushi Iwama
Oct 12, 2012·International Journal of Hematology·Jumpei Yamazaki, Jean-Pierre J Issa
Dec 13, 2012·International Journal of Hematology·Jelena D Milosevic, Robert Kralovics
Jan 30, 2013·International Journal of Hematology·Tomoki Naoe, Hitoshi Kiyoi
Oct 1, 2013·Protein & Cell·Tao WangPeng Jin
Jan 26, 2012·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Marta Sánchez-Carbayo
Aug 1, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Lee J Martin, Margaret Wong
Oct 24, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Chendhore S VeerappanGiovanni Coppola
Oct 24, 2013·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Yi-Lan WengGuo-li Ming
Jan 24, 2012·Cancer Letters·Ho-Sun Lee, Zdenko Herceg
Mar 7, 2012·Cancer Letters·Karen ChiamTina Bianco-Miotto
May 15, 2013·International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience·Javier Cortés-MendozaLeonor Pérez-Martínez
Jan 29, 2013·Molecular Aspects of Medicine·Lei LiJurrien Dean
May 7, 2013·Neuropharmacology·Eric J Nestler
Mar 5, 2013·Progress in Biophysics and Molecular Biology·Rocio Melissa Rivera, Jason Wayne Ross
Sep 3, 2011·Cell Stem Cell·Luisa CimminoIannis Aifantis
Mar 5, 2013·Trends in Biochemical Sciences·Albert Jeltsch
Aug 13, 2013·Trends in Biochemical Sciences·Chun-Xiao Song, Chuan He
Jun 5, 2013·Trends in Neurosciences·Janine M LaSalleDag H Yasui
Jan 26, 2011·Expert Reviews in Molecular Medicine·Santiago Uribe-LewisAdele Murrell
May 28, 2011·Accounts of Chemical Research·Chengqi Yi, Tao Pan

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.